---
title: 'Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers'
date: '2023-08-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37628978/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230826181110&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Epidemiological data highlight prostate cancer as a significant global
  health issue, with high incidence and substantial impact on patients' quality of
  life. The prevalence of this disease is associated with various factors, including
  age, heredity, and race. Recent research in prostate cancer genetics has identified
  several genetic variants that may be associated with an increased risk of developing
  the disease. However, despite the significance of these findings, genetic markers
  for ...
disable_comments: true
---
Epidemiological data highlight prostate cancer as a significant global health issue, with high incidence and substantial impact on patients' quality of life. The prevalence of this disease is associated with various factors, including age, heredity, and race. Recent research in prostate cancer genetics has identified several genetic variants that may be associated with an increased risk of developing the disease. However, despite the significance of these findings, genetic markers for ...